По вашему запросу найдено документов: 166

Страница 1 из 17

ЭКУЛИЗУМАБ В ТЕРАПИИ ПАТОЛОГИИ СИСТЕМЫ КОМПЛЕМЕНТА ПРИ ПАРОКСИЗМАЛЬНОЙ НОЧНОЙ ГЕМОГЛОБИНУРИИ
ECULIZUMAB IN THE TREATMENT OF COMPLEMENT SYSTEM DISORDERS INCLUDING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
BAKIROV B.A., KUDLAY D.A., PAVLOV V.N., БАКИРОВ, Б.А., КУДЛАЙ, Д.А., В.Н. Павлов (2020)
ECULIZUMAB IN THE TREATMENT OF COMPLEMENT SYSTEM DISORDERS INCLUDING PAROXYSMAL NOCTURNAL
Современные и разрабатываемые биотехнологические препараты для лечения патологии системы комплемента при пароксизмальной ночной гемоглобинурии
Biotechnological products for the treatment of complement system disorders including paroxysmal nocturnal hemoglobinuria: currently available and in development
Kudlay, D.A., Bakirov, B.A., Pavlov, V.N., Кудлай, Д.А., Бакиров, Б.А., В.Н. Павлов (2020)
Biotechnological products for the treatment of complement system disorders including paroxysmal
Thioterpenoids as Potential Antithrombotic Drugs: Molecular Docking, Antiaggregant, Anticoagulant and Antioxidant Activities
Ksenofontov, Alexander A., Bocharov, Pavel S., Antina, Elena V., Shevchenko, Oksana G., Samorodov, Aleksandr V., Gilfanov, Ilmir R., Pavelyev, Roman S., Ostolopovskaya, Olga V., Startseva, Valeriya A., Fedyunina, Inna V., Azizova, Zulfiya R., Gaysin, Salavat I. (2022)
able to inhibit erythrocyte oxidative hemolysis, to reduce the accumulation of secondary LPO products
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Onorato, Eustaquio Maria, Onorato, Eustaquio Maria, Muratori, Manuela, Smolka, Grzegorz, Wojakowski, Wojtek, Pysz, Piotr, Zorinas, Aleksejus, Zakarkaite, Diana, Eltchaninoff, Hélène, Litzer, Pierre-Yves, Godart, François, Calvert, Patrick, Christou, Christos, Mussayev, Abdurashid, Missiroli, Bindo, Buzaev, Igor, Curello, Salvatore, Tesorio, Tullio, Bartorelli, Antonio Luca (2022)
to 14.1% at 2-year follow-up (FAS). The proportion of FAS patients needing hemolysis-related blood
Safety, Efficacy and Long-Term Outcomes of Patients Treated with the Occlutech Paravalvular Leak Device for Significant Paravalvular Regurgitation
Onorato, EM, Alamanni, F, Muratori, M, Smolka, G, Wojakowski, W, Pysz, P, Zorinas, A, Zakarkaite, D, Eltchaninoff, H, Litzer, PY, Godart, F, Calvert, P, Christou, C, Mussayev, A, Missiroli, B, Buzaev, I, Curello, S, Tesorio, T, Bartorelli, AL (2022)
80% at baseline to 14.1% at 2-year follow-up (FAS). The proportion of FAS patients needing hemolysis
ПРИРОДА МОНОКЛОНАЛЬНОГО АНТИТЕЛА ЭКУЛИЗУМАБ И ЕГО ПОТЕНЦИАЛ В ОТНОШЕНИИ КОРОНАВИРУСНОЙ ИНФЕКЦИИ COVID-19
THE NATURE OF ECULIZUMAB MONOCLONAL ANTIBODY AND ITS POTENTIAL AGAINST CORONAVIRUS INFECTION COVID-19
КУДЛАЙ, Д.А., БАКИРОВ, Б.А., В.Н. Павлов, KUDLAY, D.A., BAKIROV, B.A., V.N. Pavlov (2020)
COMPLEMENT SYSTEM
КРИТЕРИИ ЭКОЛОГИЧЕСКОЙ БЕЗОПАСНОСТИ ТЯЖЕЛЫХ МЕТАЛЛОВ В КРОВИ ЧЕЛОВЕКА
Карамова, Л.М., Ларионова, Т.К., Башарова, Г.Р., Karamova, L.M., Larionova, T.K., Basharova, G.R. (2010)
and simultaneously homeostasis parameters (hemolysis, biochemistry, immunologic) should be measured - clinically
Synthesis and structure-activity-toxicity relationships of DABCO-containing ammonium amphiphiles based on natural isatin scaffold
Pashirova, T.N., Shaihutdinova, Z.M., Vandyukov, A.E., Lyubina, A.P., Amerhanova, S.K., Voloshina, A.D., Samorodov, A.V., Souto, E.B., Mironov, V.F., Mironov, V.F. (2022)
toxicity and low hemolysis (IC50 and HC50 are ≥ 100 µM, negligible coagulation) and with high biological
Заболевания спектра оптиконевромиелита (ЗСОНМ) – диагностические критерии и подходы к терапии
Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD)
Simaniv, T.O., Bakhtiyarova, K.Z., Belova, A.N., Goncharova, Z.A., Sivertseva, S.A., Spirin, N.N., Totolyan, N.A., Trushnikova, T.N., Turova, E.L., Khaibullin, T.I., Sherman, M.A., Симанив, Т.О., Бахтиярова, К.З., Белова, А.Н., Гончарова, З.А., Сиверцева, С.А., Спирин, Н.Н., Тотолян, Н.А., Трушникова, Т.Н., Турова, Е.Л., Хайбуллин, Т.И., Шерман, М.А., Бойко, А.Н. (2023)
Complement C5 inhibitors
Effect of mesenchymal stem cell-derived exosomes on the inflammatory response after stroke
Beylerli, Ozal, Gareev, Ilgiz, Shi, Huaizhang, Ilyasova, Tatiana (2024)
remarkable ability to modulate various immune cells and inflammatory mediators, thereby exerting profound

Страница 1 из 17

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год